Ovid Therapeutics Inc
(OVID)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,301 | 27,042 | 44,868 | 187,798 | 72,034 |
| Marketable Securities | 26,774 | 78,792 | 84,134 | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 142 |
| Other current assets | 2,865 | 3,764 | 2,379 | 2,682 | 2,668 |
| TOTAL | $55,940 | $109,598 | $131,381 | $190,479 | $74,843 |
| Non-Current Assets | |||||
| PPE Net | 433 | 769 | 1,148 | 243 | 136 |
| Investments And Advances | 20,974 | 17,626 | 5,623 | 1,632 | 151 |
| Other Non-Current Assets | 14,820 | 16,035 | 17,115 | 2,191 | 796 |
| TOTAL | $36,227 | $34,430 | $23,885 | $4,066 | $1,082 |
| Total Assets | $92,167 | $144,027 | $155,266 | $194,545 | $75,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,191 | 3,703 | 1,953 | 7,127 | 5,446 |
| Accrued Expenses | 5,994 | 6,524 | 4,505 | 7,671 | 12,033 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,371 |
| TOTAL | $10,522 | $11,473 | $6,992 | $14,798 | $22,063 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 61 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,213 |
| Other Non-Current Liabilities | 0 | 30,000 | 0 | 0 | 0 |
| TOTAL | $13,419 | $44,756 | $16,002 | $N/A | $10,231 |
| Total Liabilities | $23,941 | $56,230 | $22,993 | $14,798 | $32,294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,075 | 70,710 | 70,492 | 70,373 | 65,754 |
| Common Shares | 71 | 71 | 71 | 70 | 66 |
| Retained earnings | -304,299 | -277,865 | -225,527 | -171,358 | -294,192 |
| Other shareholders' equity | -35 | 0 | -42 | 0 | 0 |
| TOTAL | $68,226 | $87,797 | $132,273 | $179,746 | $43,632 |
| Total Liabilities And Equity | $92,167 | $144,027 | $155,266 | $194,545 | $75,926 |